Literature DB >> 15982300

Peptidylarginine deiminase isoforms are differentially expressed in the anagen hair follicles and other human skin appendages.

Rachida Nachat1, Marie-Claire Méchin, Marie Charveron, Guy Serre, Jacques Constans, Michel Simon.   

Abstract

Peptidylarginine deiminases (PAD) catalyze the conversion of arginine residues to citrullines. Five isoforms are known that present distinct tissue locations. In the epidermis, like in the skin, only PAD1, 2, and 3 are expressed. Their pattern of expression in skin appendages is not known. Here, confocal microscopy analysis using highly specific antibodies demonstrated that PAD1 and 3 are expressed in human anagen hair follicles, PAD1 and 2, in arrector pili muscles and sweat glands, whereas no PAD were detected in sebaceous glands. PAD1 was detected in the cuticle and the Huxley layer of the inner root sheath (IRS), and in the companion layer. PAD3 was localized in the medulla, and in the three layers of the IRS. Using anti-modified citrulline antibodies, we also showed that deiminated proteins appeared in the lower part of the IRS, first in the Henle layer, then in the cuticle, and finally in the Huxley layer. Our data demonstrate that PAD3 is the enzyme that deiminates trichohyalin in the medulla and the Henle layer, indicate that PAD1 and 3 are involved in the hair follicle program of differentiation, and suggest a role for PAD1 and 2 in the physiology of sweat glands and arrector pili muscles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15982300     DOI: 10.1111/j.0022-202X.2005.23763.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  21 in total

1.  Deimination is regulated at multiple levels including auto-deimination of peptidylarginine deiminases.

Authors:  Marie-Claire Méchin; Fanny Coudane; Véronique Adoue; Jacques Arnaud; Hélène Duplan; Marie Charveron; Anne-Marie Schmitt; Hidenari Takahara; Guy Serre; Michel Simon
Journal:  Cell Mol Life Sci       Date:  2010-01-29       Impact factor: 9.261

Review 2.  Peptidylarginine deiminase and protein citrullination in prion diseases: strong evidence of neurodegeneration.

Authors:  Byungki Jang; Akihito Ishigami; Naoki Maruyama; Richard I Carp; Yong-Sun Kim; Eun-Kyoung Choi
Journal:  Prion       Date:  2012-09-28       Impact factor: 3.931

3.  Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type III.

Authors:  Masaki Unno; Kenji Kizawa; Makiko Ishihara; Hidenari Takahara
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-05-23

4.  Crystallization and preliminary X-ray crystallographic analysis of human peptidylarginine deiminase type I.

Authors:  Masaki Unno; Saya Kinjo; Kenji Kizawa; Hidenari Takahara
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-11-28

5.  Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.

Authors:  Bryan Knuckley; Corey P Causey; Justin E Jones; Monica Bhatia; Christina J Dreyton; Tanesha C Osborne; Hidenari Takahara; Paul R Thompson
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

6.  NF-Y and Sp1/Sp3 are involved in the transcriptional regulation of the peptidylarginine deiminase type III gene (PADI3) in human keratinocytes.

Authors:  Sijun Dong; Takuya Kanno; Ayako Yamaki; Toshio Kojima; Masakazu Shiraiwa; Akira Kawada; Marie-Claire Méchin; Stéphane Chavanas; Guy Serre; Michel Simon; Hidenari Takahara
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

Review 7.  Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?

Authors:  Pamela Mangat; Natalia Wegner; Patrick J Venables; Jan Potempa
Journal:  Arthritis Res Ther       Date:  2010-06-02       Impact factor: 5.156

Review 8.  Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.

Authors:  Shu Wang; Yanming Wang
Journal:  Biochim Biophys Acta       Date:  2013-07-13

Review 9.  Histone citrullination: a new target for tumors.

Authors:  Dongwei Zhu; Yue Zhang; Shengjun Wang
Journal:  Mol Cancer       Date:  2021-06-11       Impact factor: 27.401

Review 10.  Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.

Authors:  Mei-Ling Yang; Fernanda M C Sodré; Mark J Mamula; Lut Overbergh
Journal:  Front Immunol       Date:  2021-06-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.